Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary
Home > Formulary : Adult > Local Guidelines >

2. Cardiovascular System Guidelines

Anticoagulation Guidance

DOAC Decision Aid Tool for non-valvular AF

Summary of considerations when prescribing a DOAC in non-valvular AF

BNSSG Guidance on switching between oral anticoagulants (July 2022)

BNSSG ICS Warfarin Counselling checklist 

BNSSG ICS DOACs Counselling checklist 

Shared decision making tool - Low dose Rivaroxaban plus aspirin for prevention of Cardiovascular events 

Management of Subtherapeutic INR in the community

Management of High INR in the community.

 

Anticoagulation Patient Information

Apixaban

Dabigatran 

Edoxaban

Rivaroxaban

 

Antiplatelet Guidance

BNSSG Guidelines for the Prescribing of Antiplatelets

 

Heart Failure Guidance

Primary Care Heart Failure Treatment Guideline

Practical Guidance on how to use Heart Failure Medications

Traffic light: How to monitor renal function and potassium rises in stable Heart Failure

Use of Dapagliflozin & Empagliflozin (SGLT2i) in Patients with Heart Failure

See Endocrine System Guidelines page for the 'Advice on the use of SGLT-2 inhibitors in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease'

 

Lipid Guidance

Combined Bristol Lipid Guidelines

Inclisiran Information for Primary Care

 

For guidelines relating to appliances and devices, including hosiery and garments, see 20. Appliances and Part IX